Skip to content

Comparison of Oncoplastic and Conventional breast surgery

Comparison of Oncological and Cosmetic Outcomes in patients undergoing Oncoplastic vs Conventional (non-Oncoplastic) Breast Conservation Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/12/077661
Enrollment
376
Registered
2024-12-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C50- Malignant neoplasm of breast

Interventions

Intervention1: NIL: NIL Control Intervention1: Nil: Nil

Sponsors

SGPGI LUCKNOW
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Female patients diagnosed with early breast cancer (EBC) or locally advanced breast cancer (LABC) who have undergone breast conservation surgery at SGPGIMS. 2 Patients who are candidates for breast-conserving surgery (BCS), either as primary surgery or after neoadjuvant chemotherapy (NACT). 3 Patients who consent to participate in the study and complete the required questionnaires.

Exclusion criteria

Exclusion criteria: •Patients with Metastatic Breast cancer •Patients requiring mastectomy due to tumor size, multifocality, extensive microcalcifications, or any other clinical factors •Insufficient data or follow up

Design outcomes

Primary

MeasureTime frame
To compare Margin infiltrating rate (MIR) i.e, positive margins on Frozen section biopsy between both groups To compare Ipsilateral breast tumor recurrence (IBTR) rate between both groups. Timepoint: At surgery

Secondary

MeasureTime frame
To Compare patient satisfaction regarding breast shape, volume, symmetry, scar and overall satisfaction To compare the re-excision rate between both groups To estimate Overall Survival (OS) and disease-free survival rates (DFS) To evaluate rate of conversion to mastectomy between both groups Timepoint: 6 months for Patient satisfaction and during follow up period

Countries

India

Contacts

Public ContactMithlesh Wanchoo

SGPGI

gaurav@agpgi.ac.in8004904646

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026